Role for ephrinB2 in postnatal lung alveolar development and elastic matrix integrity

Developmental Dynamics

Volumn 237, Issue 8, 2008, Pages 2220-2234

  Wilkinson, George A ^a,d   Schittny, Johannes C ^b   Reinhardt, Dieter P ^c   Klein, Rüdiger ^a  

^a MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c MCGILL UNIVERSITY   (Canada)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Elastic matrix; Endothelial; ephrinb2; Fibronectin; Lung development; PDZ domain; Secondary septum

Indexed keywords

EPHRIN B2; PDZ PROTEIN;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL POPULATION; CONTROLLED STUDY; EMBRYO; EXTRACELLULAR MATRIX; HOMOZYGOSITY; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG MALFORMATION; MICROVASCULATURE; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION;

ACTINS; ANIMALS; ELASTICITY; ELASTIN; EPHRIN-B2; EPHRIN-B3; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIGANDS; MICE; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; MICROFILAMENT PROTEINS; MICROSCOPY, ELECTRON; PULMONARY ALVEOLI; RECEPTORS, EPH FAMILY; RESPIRATORY MUCOSA;

MUS;

EID: 49449110979     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21643     Document Type: Article

References (97)

1. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, Risau W, Klein R. 1999. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 13: 295-306.
2. Adams RH, Diella F, Hennig S, Helmbacher F, Deutsch U, Klein R. 2001. The cytoplasmic domain of the ligand ephrinB2 is required for vascular morphogenesis but not cranial neural crest migration. Cell 104:57-69.
3. Adler KB, Low RB, Leslie KO, Mitchell J, Evans JN. 1989. Contractile cells in normal and fibrotic lung. Lab Invest 60:473-485.
4. Altschuler Y, Hodson C, Milgram SL. 2003. The apical compartment: trafficking pathways, regulators and scaffolding proteins. Curr Opin Cell Biol 15:423-429.
5. Amy RW, Bowes D, Burri PH, Haines J, Thurlbeck WM. 1977. Postnatal growth of the mouse lung. J Anat 124:131-151.
6. Ayadi A, Zheng H, Sobieszczuk P, Buchwalter G, Moerman P, Alitalo K, Wasylyk B. 2001. Net-targeted mutant mice develop a vascular phenotype and upregulate egr-1. EMBO J 20:5139-5152.
7. Balasubramaniam V, Tang JR, Maxey A, Plopper CG, Abman SH. 2003. Mild hypoxia impairs alveolarization in the endothelial nitric oxide synthase-deficient mouse. Am J Physiol Lung Cell Mol Physiol 284:L964-L971.
8. Balasubramaniam V, Maxey AM, Fouty BW, Abman SH. 2006. Nitric oxide augments fetal pulmonary artery endothelial cell angiogenesis in vitro. Am J Physiol Lung Cell Mol Physiol 290: L1111-L1116.
9. Barrios A, Poole RJ, Durbin L, Brennan C, Holder N, Wilson SW. 2003. Eph/Ephrin signaling regulates the mesenchymal-to-epithelial transition of the paraxial mesoderm during somite morphogenesis. Curr Biol 13:1571-1582.
10. Betsholtz C, Lindblom P, Gerhardt H. 2005. Role of pericytes in vascular morphogenesis. EXS 115-125.
11. Bostrom H, Willetts K, Pekny M, Leveen P, Lindahl P, Hedstrand H, Pekna M, Hellstrom M, Gebre-Medhin S, Schalling M, Nilsson M, Kurland S, Tornell J, Heath JK, Betsholtz C. 1996. PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis. Cell 85:863-873.
12. Bourbon J, Boucherat O, Chailley-Heu B, Delacourt C. 2005. Control mechanisms of lung alveolar development and their disorders in bronchopulmonary dysplasia. Pediatr Res 57:38R-46R.
13. Bouzioukh F, Wilkinson GA, Adelmann G, Frotscher M, Stein V, Klein R. 2007. Tyrosine phosphorylation sites in ephrinB2 are required for hippocampal long-term potentiation but not long-term depression. J Neurosci 27:11279-11288.
14. Bruckner K, Pablo Labrador J, Scheiffele P, Herb A, Seeburg PH, Klein R. 1999. EphrinB ligands recruit GRIP family PDZ adaptor proteins into raft membrane microdomains. Neuron 22:511-524.
15. Burri PH. 1984. Fetal and postnatal development of the lung. Annu Rev Physiol 46:617-628.
16. Burri PH. 2006. Structural aspects of postnatal lung development - alveolar formation and growth. Biol Neonate 89:313-322.
17. Chong SW, Jiang YJ. 2005. Off limits - integrins holding boundaries in somitogenesis. Trends Cell Biol 15:453-457.
18. Coalson JJ. 2006. Pathology of bronchopulmonary dysplasia. Semin Perinatol 30: 179-184.
19. Conforti E, Fenoglio C, Bernocchi G, Bruschi O, Miserocchi GA. 2002. Morphofunctional analysis of lung tissue in mild interstitial edema. Am J Physiol Lung Cell Mol Physiol 282:L766-L774.
20. Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M. 2004. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development. Dev Biol 271:263-271.
21. Daffara R, Botto L, Beretta E, Conforti E, Faini A, Palestini P, Miserocchi G. 2004. Endothelial cells as early sensors of pulmonary interstitial edema. J Appl Physiol 97:1575-1583.
22. Davis S, Gale NW, Aldrich TH, Maisonpierre PC, Lhotak V, Pawson T, Goldfarb M, Yancopoulos GD. 1994. Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. Science 266:816-819.
23. Davy A, Aubin J, Soriano P. 2004. Ephrin-B1 forward and reverse signaling are required during mouse development. Genes Dev 18:572-583.
24. Dravis C, Yokoyama N, Chumley MJ, Cowan CA, Silvany RE, Shay J, Baker LA, Henkemeyer M. 2004. Bidirectional signaling mediated by ephrin-B2 and EphB2 controls urorectal development. Dev Biol 271:272-290.
25. Dunsmore SE, Rannels DE. 1996. Extracellular matrix biology in the lung. Am J Physiol 270:L3-L27.
26. Egea J, Nissen UV, Dufour A, Sahin M, Greer P, Kullander K, Mrsic-Flogel TD, Greenberg ME, Kiehn O, Vanderhaeghen P, Klein R. 2005. Regulation of EphA 4 kinase activity is required for a subset of axon guidance decisions suggesting a key role for receptor clustering in Eph function. Neuron 47:515-528.
27. Foo SS, Turner CJ, Adams S, Compagni A, Aubyn D, Kogata N, Lindblom P, Shani M, Zicha D, Adams RH. 2006. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly. Cell 124: 161-173.
28. Foster JJ, Goss KL, George CL, Bangsund PJ, Snyder JM. 2006. Galectin-1 in secondary alveolar septae of neonatal mouse lung. Am J Physiol Lung Cell Mol Physiol 291:L1142-L1149.
29. Frasca JM, Parks VR. 1965. A routine technique for double-staining ultrathin sections using uranyl and lead salts. J Cell Biol 25:157-161.
30. Galambos C, Demello DE. 2008. Regulation of alveologenesis: clinical implications of impaired growth. Pathology 40: 124-140.
31. Gale NW, Baluk P, Pan L, Kwan M, Holash J, DeChiara TM, McDonald DM, Yancopoulos GD. 2001. Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230:151-160.
32. Gerety SS, Anderson DJ. 2002. Cardiovascular ephrinB2 function is essential for embryonic angiogenesis. Development 129:1397-1410.
33. Gerety SS, Wang HU, Chen ZF, Anderson DJ. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol Cell 4:403-414.
34. Grunwald IC, Korte M, Wolfer D, Wilkinson GA, Unsicker K, Lipp HP, Bonhoeffer T, Klein R. 2001. Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 32: 1027-1040.
35. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM. 2005. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 85:979-1000.
36. Henkemeyer M, Orioli D, Henderson JT, Saxton TM, Roder J, Pawson T, Klein R. 1996. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86:35-46.
37. Heroult M, Schaffner F, Augustin HG. 2006. Eph receptor and ephrin ligand-mediated interactions during angiogenesis and tumor progression. Exp Cell Res 312:642-650.
38. Hetzel M, Bachern M, Anders D, Trischler G, Faehling M. 2005. Different effects of growth factors on proliferation and matrix production of normal and fibrotic human lung fibroblasts. Lung 183:225-237.
39. Huang XZ, Wu JF, Ferrando R, Lee JH, Wang YL, Farese RV Jr, Sheppard D. 2000. Fatal bilateral chylothorax in mice lacking the integrin alpha9beta1. Mol Cell Biol 20:5208-5215.
40. Huynh-Do U, Stein E, Lane AA, Liu H, Cerretti DP, Daniel TO. 1999. Surface densities of ephrin-B1 determine EphB1-coupled activation of cell attachment through alphavbeta3 and alpha5beta1 integrals. EMBO J 18:2165-2173.
41. Huynh-Do U, Vindis C, Liu H, Cerretti DP, McGrew JT, Enriquez M, Chen J, Daniel TO. 2002. Ephrin-B1 transduces signals to activate integrin-mediated migration, attachment and angiogenesis. J Cell Sci 115:3073-3081.
42. Jakkula M, Le Cras TD, Gebb S, Hirth KP, Tuder RM, Voelkel NF, Abman SH. 2000. Inhibition of angiogenesis decreases alveolarization in the developing rat lung. Am J Physiol Lung Cell Mol Physiol 279:L600-L607.
43. Jostarndt-Fogen K, Djonov V, Draeger A. 1998. Expression of smooth muscle markers in the developing murine lung: potential contractile properties and lineal descent. Histochem Cell Biol 110:273-284.
44. Kalluri R. 2003. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:422-433.
45. Koshida S, Kishimoto Y, Ustumi H, Shimizu T, Furutani-Seiki M, Kondoh H, Takada S. 2005. Integrinalpha5-dependent fibronectin accumulation for maintenance of somite boundaries in zebrafish embryos. Dev Cell 8:587-598.
46. Le Cras TD, Markham NE, Tuder RM, Voelkel NF, Abman SH. 2002. Treatment of newborn rats with a VEGF receptor inhibitor causes pulmonary hypertension and abnormal lung structure. Am J Physiol Lung Cell Mol Physiol 283: L555-L562.
47. Lee HS, Bong YS, Moore KB, Soria K, Moody SA, Daar IO. 2006. Dishevelled mediates ephrinB1 signalling in the eye field through the planar cell polarity pathway. Nat Cell Biol 8:55-63.
48. Leighton PA, Mitchell KJ, Goodrich LV, Lu X, Pinson K, Scherz P, Skarnes WC, Tessier-Lavigne M. 2001. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410:174-179.
49. Lindahl P, Karlsson L, Hellstrom M, Gebre-Medhin S, Willetts K, Heath JK, Betsholtz C. 1997. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. De-velopment 124:3943-3953.
50. Loscertales M, Mikels AJ, Hu JK, Donahoe PK, Roberts DJ. 2008. Chick pulmonary Wnt5a directs airway and vascular tubulogenesis. Development 135:1365-1376.
51. Lu Q, Sun EE, Klein RS, Flanagan JG. 2001. Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105:69-79.
52. Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA. 2005. PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature. Genes Dev 19: 397-410.
53. Mao Y, Schwarzbauer JE. 2005. Fibronectin fibrillogenesis, a cell-mediated matrix assembly process. Matrix Biol 24: 389-399.
54. Mariani TJ, Reed JJ, Shapiro SD. 2002. Expression profiling of the developing mouse lung: insights into the establishment of the extracellular matrix. Am J Respir Cell Mol Biol 26:541-548.
55. Massaro D, Massaro GD. 2001. Pulmonary alveolus formation: critical period, retinoid regulation and plasticity. Novartis Found Symp 234:229-236; discussion 236-241.
56. Matsuoka H, Iwata N, Ito M, Shimoyama M, Nagata A, Chihara K, Takai S, Matsui T. 1997. Expression of a kinase-defective Eph-like receptor in the normal human brain. Biochem Biophys Res Commun 235:487-492.
57. McGowan SE, Torday JS. 1997. The pulmonary lipofibroblast (lipid interstitial cell) and its contributions to alveolar development. Annu Rev Physiol 59:43-62.
58. Merrill RA, Ahrens JM, Kaiser ME, Federhart KS, Poon VY, Clagett-Dame M. 2004. All-trans retinoic acid-responsive genes identified in the human SH-SY5Y neuroblastoma cell line and their regulated expression in the nervous system of early embryos. Biol Chem 385:605-614.
59. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B, Ramirez F, Sakai LY, Dietz HC. 2003. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33:407-411.
60. Nguyen NM, Senior RM. 2006. Laminin isoforms and lung development: all isoforms are not equal. Dev Biol 294:271-279.
61. Oike Y, Ito Y, Hamada K, Zhang XQ, Miyata K, Arai F, Inada T, Araki K, Nakagata N, Takeya M, Kisanuki YY, Yanagisawa M, Gale NW, Suda T. 2002. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells. Blood 100:1326-1333.
62. Orioli D, Henkemeyer M, Lemke G, Klein R, Pawson T. 1996. Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J 15:6035-6049.
63. Palmer A, Zimmer M, Erdmann KS, Eulenburg V, Porthin A, Heumann R, Deutsch U, Klein R. 2002. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol Cell 9:725-737.
64. Parameswaran K, Willems-Widyastuti A, Alagappan VK, Radford K, Kranenburg AR, Sharma HS. 2006. Role of extracellular matrix and its regulators in human airway smooth muscle biology. Cell Biochem Biophys 44:139-146.
65. Pasquale EB. 2005. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6:462-475.
66. Pierce RA, Joyce B, Officer S, Heintz C, Moore C, McCurnin D, Johnston C, Maniscalco W. 2007. Retinoids increase lung elastin expression but fail to alter morphology or angiogenesis genes in premature ventilated baboons. Pediatr Res 61:703-709.
67. Postma DS, Timens W. 2006. Remodeling in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 3:434-439.
68. Prevost N, Woulfe DS, Jiang H, Stalker TJ, Marchese P, Ruggeri ZM, Brass LF. 2005. Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets. Proc Natl Acad Sci U S A 102: 9820-9825.
69. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208-212.
70. Roth-Kleiner M, Post M. 2005. Similarities and dissimilarities of branching and septation during lung development. Pediatr Pulmonol 40:113-134.
71. Schittny JC, Burri PH. 2004. Morphogenesis of the mammalian lung: aspects of structure and extracellular matrix components. In: Massaro D, Massaro GD, Chambon P, editors. Lung development and regeneration. New York: Marcel Dekker Inc. p 275-317.
72. Schittny JC, Paulsson M, Vallan C, Burri PH, Kedei N, Aeschlimann D. 1997. Protein cross-linking mediated by tissue transglutaminase correlates with the maturation of extracellular matrices during lung development. Am J Respir Cell Mol Biol 17:334-343.
73. Schittny JC, Djonov V, Fine A, Burri PH. 1998. Programmed cell death contributes to postnatal lung development. Am J Respir Cell Mol Biol 18:786-793.
74. Sen J, Harpavat S, Peters MA, Cepko CL. 2005. Retinoic acid regulates the expression of dorsoventral topographic guidance molecules in the chick retina. Development 132:5147-5159.
75. Shifren A, Mecham RP. 2006. The stumbling block in lung repair of emphysema: elastic fiber assembly. Proc Am Thorac Soc 3:428-433.
76. Shin D, Garcia-Cardena G, Hayashi S, Gerety S, Asahara T, Stavrakis G, Isner J, Folkman J, Gimbrone MA Jr, Anderson DJ. 2001. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230:139-150.
77. Stallcup WB. 2002. The NG2 proteoglycan: past insights and future prospects. J Neurocytol 31:423-435.
78. Stein E, Lane AA, Cerretti DP, Schoeck-lmann HO, Schroff AD, Van Etten RL, Daniel TO. 1998. Eph receptors discriminate specific ligand oligomers to determine alternative signaling complexes, attachment, and assembly responses. Genes Dev 12:667-678.
79. Stenmark KR, Abman SH. 2005. Lung vascular development: implications for the pathogenesis of bronchopulmonary dysplasia. Annu Rev Physiol 67:623-661.
80. Stinchcombe SV, Maden M. 2008. Retinoic acid induced alveolar regeneration: critical differences in strain sensitivity. Am J Respir Cell Mol Biol 38:185-191.
81. Surawska H, Ma PC, Salgia R. 2004. The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15:419-433.
82. Thannickal VJ, Lee DY, White ES, Cui Z, Larios JM, Chacon R, Horowitz JC, Day RM, Thomas PE. 2003. Myofibroblast differentiation by transforming growth factor-beta1 is dependent on cell adhesion and integrin signaling via focal adhesion kinase. J Biol Chem 278:12384-12389.
83. Thebaud B. 2007. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 91:291-297.
84. Tiedemann K, Batge B, Muller PK, Reinhardt DP. 2001. Interactions of fibrillin-1 with heparin/heparan sulfate, implications for microfibrillar assembly. J Biol Chem 276:36035-36042.
85. Torres R, Firestein BL, Dong H, Staudinger J, Olson EN, Huganir RL, Bredt DS, Gale NW, Yancopoulos GD. 1998. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 21:1453-1463.
86. Umeda N, Ozaki H, Hayashi H, Oshima K. 2004. Expression of ephrinB2 and its receptors on fibroproliferative membranes in ocular angiogenic diseases. Am J Ophthalmol 138:270-279.
87. Urena JM, Merlos-Suarez A, Baselga J, Arribas J. 1999. The cytoplasmic carboxy-terminal amino acid determines the subcellular localization of proTGF-(alpha) and membrane type matrix metalloprotease (MTl-MMP). J Cell Sci 112:773-784.
88. Voelkel NF, Vandivier RW, Tuder RM. 2006. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290:L209-L221.
89. Wade KC, Guttentag SH, Gonzales LW, Maschhoff KL, Gonzales J, Kolla V, Singhal S, Ballard PL. 2006. Gene induction during differentiation of human pulmonary type II cells in vitro. Am J Respir Cell Mol Biol 34:727-737.
90. Wagner TE, Frevert CW, Herzog EL, Schnapp LM. 2003. Expression of the integrin subunit alpha8 in murine lung development. J Histochem Cytochem 51: 1307-1315.
91. Wang HU, Chen ZF, Anderson DJ. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93:741-753.
92. Weinstein M, Xu X, Ohyama K, Deng CX. 1998. FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125:3615-3623.
93. Yamada M, Kurihara H, Kinoshita K, Sakai T. 2005. Temporal expression of alpha-smooth muscle actin and drebrin in septal interstitial cells during alveolar maturation. J Histochem Cytochem 53: 735-744.
94. Yamamoto H, Yun EJ, Gerber HP, Ferrara N, Whitsett JA, Vu TH. 2007. Epithelial-vascular cross talk mediated by VEGF-A and HGF signaling directs primary septae formation during distal lung morphogenesis. Dev Biol 308:44-53.
95. Zhang J, Hughes S. 2006. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system. J Pathol 208:453-461.
96. Zhang XQ, Takakura N, Oike Y, Inada T, Gale NW, Yancopoulos GD, Suda T. 2001. Stromal cells expressing ephrin-B2 promote the growth and sprouting of ephrin-B2(+) endothelial cells. Blood 98: 1028-1037.
97. Zhao Y, Young SL. 1995. Tenascin in rat lung development: in situ localization and cellular sources. Am J Physiol 269: L482-L491.